Thrombin leads to blood clotting through activation of specialized G protein–coupled receptors. In mice, small peptides call pepducins inhibit thrombin receptors and prevent blood clotting (pages 1161–1165).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Debbie Maizels
References
Dang, Q., Vindigni, A. & DiCera, E. An allosteric switch control the procoagulant and anticoagulant activities of thrombin. Proc. Nat. Acad. Sci. USA 92, 5977–5981 (1995).
Covic, L., Misra, M., Badar, J., Singh, C. & Kuliopulos, A. Pepducin-based intervention of thrombin receptor signaling and systemic platelet activation. Nature Med. 8, 1161–1165 (2002).
Cotecchia, S., Ostrowski, J., Kjelsberg, M., Caron, M. & Lefkowitz, R. Discrete amino acid sequences of the alpha 1-adrenergic receptor determine the selectivity of coupling to phosphatidylinositol hydrolysis. J Biol Chem 267, 1633–1639 (1992).
Nakanishi-Matsui, M. et al. PAR3 is a cofactor for PAR4 activation by thrombin. Nature 404, 609–613 (2000).
Schmidt, V. et al. The human proteolytically activated receptor-3 (PAR-3) gene: Identification within a PAR gene cluster and characterization in vascular endothelial cells and platelets, J. Bio. Chem. 273, 15061–68 (1998).
Andrade-Gordon, P. et al. Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a ththered-ligand receptor. Proc. Nat. Acad. Sci. USA 96, 12257–12262 (1999).
Hasan, A., Amenta, S. & Schmaier, A. Bradykinin and its metabolite, Arg-Pro-Pro-Gly-Phe, and selective inhibitors of alpha-thrombin induced platelet activation. Circulation 94, 517–528 (1996).
Covic, L.G.A.T.J., Swift, S. & Kuliopulos, A. Activation and inhibition of G protein–coupled receptors by cell-penetrating membrane-tethered peptides. Proc. Nat. Acad. Sci. USA 99, 643–648 (2002).
Verrall, S. et al. The thrombin receptor second cytoplasmic loop confers coupling to Gq-like G proteins in chimeric receptors. J. Biol. Chem. 272, 6898–6902 (1997).
Rocheville, M. et al. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science 288, 154–157 (2000).
Mirza, H., Yatsula, V. & Bahou, W.F. The proteinase activated receptor-2 (PAR-2) mediates mitogenic responses in human vascular endothelial cells. Molecular characterization and evidence for functional coupling to the thrombin receptor. J. Clin. Invest. 97, 1705–1714 (1996).
Kuner, R. et al. Role of heteromer formation in GABAB receptor function. Proc. Natl. Acad. Sci. USA 283, 74–77 (1999).
Cook, J. et al. An antibody against the exosite of the cloned thrombin receptor inhibits experimental arterial thrombosis in the African green monkey. Circulation 91, 2961–2971 (1995).
Venter, J. et al. The sequence of the human genome. Science 291, 1304–1351 (2001).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bahou, W. Attacked from within, blood thins. Nat Med 8, 1082–1083 (2002). https://doi.org/10.1038/nm1002-1082
Issue Date:
DOI: https://doi.org/10.1038/nm1002-1082
This article is cited by
-
Inhibition of platelet thromboxane receptor function by a thrombin receptor–targeted pepducin
Nature Medicine (2003)
-
Reply to “Inhibition of platelet thromboxane receptor function by a thrombin receptor–targeted pepducin”
Nature Medicine (2003)
-
Scientific and therapeutic advances in antiplatelet therapy
Nature Reviews Drug Discovery (2003)
